| Identification | Back Directory | [Name]
Cholic Acid Impurity (5-beta-Cholane-3-alpha-7-beta-24-Triol) | [CAS]
130593-75-8 | [Synonyms]
Cholic Acid Impurity 7
(3α,5β,7β)-Cholane-3,7,24-triol
Cholane-3,7,24-triol, (3α,5β,7β)-
Ursodeoxycholic Acid EP Impurity I
Cholic Acid Impurity (5-beta-Cholane-3-alpha-7-beta-24-Triol)
Ursodeoxycholic Acid Impurity 9（Ursodeoxycholic Acid EP Impurity I）
Ursodeoxycholic Acid EP Impurity I/5-beta-Cholane-3-alpha-7-beta-24-Triol/(3α,5β,7β)-Cholane-3,7,24-triol | [Molecular Formula]
C24H42O3 | [MOL File]
130593-75-8.mol | [Molecular Weight]
378.59 |
| Chemical Properties | Back Directory | [Melting point ]
>80°C (dec.) | [Boiling point ]
509.5±25.0 °C(Predicted) | [density ]
1.079±0.06 g/cm3(Predicted) | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
Chloroform (Slightly), DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
14.79±0.70(Predicted) | [color ]
White to Off-White | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Uses]
(3α,5β,7β)-Cholane-3,7,24-triol (Ursodeoxycholic Acid EP Impurity I) is used in the preparation of Ursodeoxycholic Acid (U850000) scaffold. Ursodeoxycholic Acid scaffold is used to generate novel and selective steroidal ligands for GP-BAR1, a promising pharmacology target for the treatment of steatohepatitis, type 2 diabetes, and obesity. |
|
| Company Name: |
TOSUN PHARM
|
| Tel: |
020-61855200 13326451905 |
| Website: |
www.toref.cn/ |
|